DMKPQ — DMK Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for DMK Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	C2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	19.3	8.81	6.86	23.2	1.08
Net Total Accounts Receivable
Net Total Receivables	1.16	1.88	1.09	5.9	1.09
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	25.8	13.9	12.5	35.2	9.27
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.87	13.5	11.1	2.99	1.61
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	58.4	47.8	30.9	38.3	10.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.6	9.41	19.9	11.2	11.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	11.7	14.8	27.4	12.4	11.6
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	46.7	33	3.5	25.9	-0.651
Total Liabilities & Shareholders' Equity	58.4	47.8	30.9	38.3	10.9
Total Common Shares Outstanding